title: [Focus on pre-exposure prophylaxis].
abstract: Pre-exposure prophylaxis currently has no market authorisation in France, but is still evaluated. This article presents an additional tool for risk reduction, currently the subject of studies.
authors.affiliation: Hôpital Saint-Antoine, AP-HP, 184 rue du Fb St-Antoine, 75012 Paris, France. emma.torres@sat.aphp.fr
authors.forename: Emma
authors.initials: E
authors.lastname: Torres
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Meynard
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D011322:Primary Prevention / Q000379:methods*
chemical_list: D044966:Anti-Retroviral Agents